SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,282.51 |
| Enterprise Value ($M) | 2,043.37 |
| Book Value ($M) | 491.14 |
| Book Value / Share | 8.38 |
| Price / Book | 4.65 |
| NCAV ($M) | 214.85 |
| NCAV / Share | 3.67 |
| Price / NCAV | 10.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.38 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.52 |
| Current Ratio | 4.91 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 361.83 |
| Assets | 638.12 |
| Liabilities | 146.98 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Invesco Ltd. | 6.30 | ||
| 13G/A | Nikko Asset Management Americas, Inc. | 4.88 | -20.16 | |
| 13G/A | Sumitomo Mitsui Trust Holdings, Inc. | 4.88 | -20.16 | |
| 13G/A | Jpmorgan Chase & Co | 4.30 | -43.77 | |
| 13G/A | Artisan Partners Limited Partnership | 10.40 | 62.99 | |
| 13G/A | Vanguard Group Inc | 9.49 | -3.90 | |
| 13G | William Blair Investment Management, Llc | 6.20 | ||
| 13G/A | Fmr Llc | 0.53 | -90.04 | |
| 13G/A | ARK Investment Management LLC | 12.51 | 7.65 | |
| 13G/A | State Street Corp | 5.83 | -24.04 | |
| 13G/A | BlackRock, Inc. | 10.30 | -4.29 | |
| 13G/A | Integrated Core Strategies (us) Llc | 3.20 | -40.21 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 622,880 | 1,841,188 | 33.83 | |
| 110,926 | 1,063,578 | 10.43 | |
| 144,746 | 858,389 | 16.86 | |
| 282,755 | 961,355 | 29.41 | |
| 114,752 | 660,761 | 17.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TRML – Tourmaline Bio, Inc. | TSHA – Taysha Gene Therapies, Inc. |
| TSVT – 2seventy bio, Inc. | TXMD – TherapeuticsMD, Inc. |
| TYRA – Tyra Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io